SECURITIES AND EXCHANGE COMMISSION

Litigation Release No. 17445 / March 27, 2002

   United States of America v. David A. Colvin, John Larson a.k.a. John
   St. John and Aldo Tarallo a.k.a. Al Tarall, CR 00-186 (C.D. Cal.)

   On March 25, 2002, the United States Attorney for the Central District
   of California announced that John Larson a.k.a. John St. John, was
   sentenced by United States District Judge Audrey B. Collins to
   forty-two months in prison and three years supervised release based
   upon his September 17, 2001, plea of guilty to securities and mail
   fraud charges. Previously, David A. Colvin was sentenced to
   seventy-eight months in prison based upon his plea of guilty to
   securities fraud, mail fraud, and money laundering charges. Both
   Colvin and Larson have also been ordered to pay restitution.

   Colvin and Larson, operating out of offices in the San Fernando Valley
   in Southern California, raised over $5.6 million from hundreds of
   investors nationwide from January 1997 until the Commission filed an
   action, SEC v. David A. Colvin; Intellinet Publishing, Inc.;
   Intellinet Holding Group, Inc.; Medical Advantage, Inc.; Lamelli, Inc.
   a/k/a Lamelli Medical Technology, Inc.; Wall Street Research Company,
   Inc.; Job Kjell Hovik; Lamar Ellis; and John Larson a/k/a John St.
   John, Civil Action No. SA98-135 AHS (EEx) (C.D. Cal.) on February 19,
   1998, and obtained a temporary restraining order, asset freeze order
   and appointment of a receiver over the entity Defendants on February
   20, 1998.

   Colvin and Larson offered and sold investments in various of the
   entity Defendants in the Commission action. They claimed Intellinet
   Publishing, Inc. was a book publishing company. They also claimed that
   Medical Advantage, Inc. operated a chain of weight loss clinics.
   Finally, they claimed that Lamelli, Inc. a/k/a Lamelli Medical
   Technology, Inc. had developed a "detoxification system" by which a
   person could be detoxified of drugs or alcohol in as little as fifteen
   minutes. In fact, Intellinet had no products, had never sold any books
   or other products, and had never produced a profit. Similarly, Medical
   Advantage was not profitable, as represented, and was unable to meet
   expenses and pay clinic employees. Representations that former U.S.
   Surgeon General C. Everett Koop and television journalist Tom Brokaw
   were affiliated with Medical Advantage were also false, as were claims
   that Lamelli had received approval of its detoxification system from
   the National Institutes of Health (NIH) and a grant from the Food and
   Drug Administration (FDA).

   Colvin and Larson falsely represented that each company would be the
   subject of an initial public offering (IPO), which offerings never in